Skip to content

Clinical trials

Completed Child Development Disorders, Pervasive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Child Development Disorders, Pervasive Status: Completed Clear all

72 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20033
20044
20051
20063
20075
20083
20094
20109
20113
20123
20135
20142
20153
20162
20173
20181
20191
20202
20214
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed72

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital7
Yale University6
Indiana University4
Children's Hospital Medical Center, Cincinnati3
National Institute of Mental Health (NIMH)3
Drexel University College of Medicine2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Ohio State University2
University of Pittsburgh2
Université de Montréal2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Child Development Disorders, Pervasive72
Autistic Disorder46
Autism Spectrum Disorder36
Asperger Syndrome26
Attention Deficit Disorder with Hyperactivity9
Anxiety Disorders4
Neurodevelopmental Disorders4
Bipolar Disorder3
Oppositional Defiant Disorder3
Rett Syndrome3

Trials

Showing 76 to 72 of 72. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.